Alan Moses
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Alan C.
Moses is currently Chairman at The diaTribe Foundation, Director-Greater New England Chapter at Breakthrough T1d, Inc., Director at Steno Diabetes Center A, Independent Director at Chemomab Therapeutics Ltd. since 2021, and Director at Advanced Regenerative Manufacturing Institute, Inc. since 2018.
Former positions include Director at New England Healthcare Institute, Independent Director at BiomX, Inc. from 2020 to 2026, Professor at Harvard University, Fellow at American College of Physicians, Inc., Chief Medical Officer & Senior Vice President at Joslin Diabetes Center, Inc. from 1998 to 2004, Global Chief Medical Officer & SVP at Novo Nordisk, Inc. in 2013, and Professor at Harvard Medical School from 2002 to 2006.
Education includes a doctorate from Washington University in St. Louis and an undergraduate degree from Duke University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Directeur/Membre du Conseil | 16/03/2021 |
Steno Diabetes Center A/S
Steno Diabetes Center A/S Miscellaneous Commercial ServicesCommercial Services Provides diabetes research laboratory services | Directeur/Membre du Conseil | - |
Advanced Regenerative Manufacturing Institute, Inc.
Advanced Regenerative Manufacturing Institute, Inc. BiotechnologyHealth Technology Operates as a non profit organization that develops and manufactures cell, tissue & organ-based products | Directeur/Membre du Conseil | 01/01/2018 |
Diatribe Foundation
Diatribe Foundation Miscellaneous Commercial ServicesCommercial Services The Diatribe Foundation is a non-profit organization that aims to help people with diabetes and prediabetes. The foundation is dedicated to bringing people with type 1 and type 2 diabetes into the conversation on regulatory issues and changing the narrative around diabetes. The company has formed The Time in Range Coalition to establish time in range as an essential part of diabetic care. The goal of the program is to improve access and quality of care for people with diabetic diseases. The company is based in San Francisco. | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMX INC. | Directeur/Membre du Conseil | 19/02/2026 |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2006 |
Joslin Diabetes Center, Inc.
Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for diabetes | Directeur Technique/Scientifique/R&D | 01/01/2004 |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services Engages in identifying innovations that improve the quality and lower the costs of health care | Directeur/Membre du Conseil | - |
American College of Physicians, Inc. /Old/
American College of Physicians, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Operates as a medical-specialty organization | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American College of Physicians, Inc. /Old/
American College of Physicians, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Operates as a medical-specialty organization | Commercial Services |
Joslin Diabetes Center, Inc.
Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for diabetes | Health Technology |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services Engages in identifying innovations that improve the quality and lower the costs of health care | Commercial Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Steno Diabetes Center A/S
Steno Diabetes Center A/S Miscellaneous Commercial ServicesCommercial Services Provides diabetes research laboratory services | Commercial Services |
Diatribe Foundation
Diatribe Foundation Miscellaneous Commercial ServicesCommercial Services The Diatribe Foundation is a non-profit organization that aims to help people with diabetes and prediabetes. The foundation is dedicated to bringing people with type 1 and type 2 diabetes into the conversation on regulatory issues and changing the narrative around diabetes. The company has formed The Time in Range Coalition to establish time in range as an essential part of diabetic care. The goal of the program is to improve access and quality of care for people with diabetic diseases. The company is based in San Francisco. | Commercial Services |
BiomX, Inc.
BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
Advanced Regenerative Manufacturing Institute, Inc.
Advanced Regenerative Manufacturing Institute, Inc. BiotechnologyHealth Technology Operates as a non profit organization that develops and manufactures cell, tissue & organ-based products | Health Technology |
Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national